尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Strange Kevin T. Officer active across 1 company, notably Inari Medical, Inc.. Cumulatively, 4 filings have been recorded. History available since 1 October 2024. The latest transaction was disclosed on 4 February 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Strange Kevin T is a declarant with 4 filings in total. The 4 sampled filings relate to Inari Medical, Inc., where he is Chief Financial Officer, between 2024-10-03 and 2025-02-19. The modal transaction nature is Attribution, and buy and sell volumes are both 0 EUR across this recent sample, with one filing of 3090.623697328759 EUR on 2025-01-03.